Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Natriuretic Peptide, Brain | 37 | 2021 | 1723 | 3.380 |
Why?
|
Heart Failure | 59 | 2021 | 11674 | 2.540 |
Why?
|
Peptide Fragments | 32 | 2021 | 5115 | 2.320 |
Why?
|
Troponin T | 10 | 2020 | 779 | 1.570 |
Why?
|
Stroke Volume | 22 | 2021 | 5497 | 1.010 |
Why?
|
Ventricular Remodeling | 10 | 2019 | 1266 | 0.960 |
Why?
|
Endothelin-1 | 4 | 2018 | 302 | 0.800 |
Why?
|
Adrenergic beta-Antagonists | 7 | 2019 | 1241 | 0.790 |
Why?
|
Dyspnea | 6 | 2021 | 1347 | 0.750 |
Why?
|
Heart Failure, Systolic | 3 | 2017 | 135 | 0.710 |
Why?
|
Receptors, Cell Surface | 7 | 2015 | 2821 | 0.680 |
Why?
|
Insulin-Like Growth Factor Binding Proteins | 6 | 2020 | 208 | 0.660 |
Why?
|
Troponin I | 7 | 2020 | 651 | 0.650 |
Why?
|
Ventricular Function, Left | 11 | 2020 | 3879 | 0.620 |
Why?
|
Ventricular Dysfunction, Left | 10 | 2020 | 2119 | 0.580 |
Why?
|
Acute Coronary Syndrome | 5 | 2018 | 2190 | 0.560 |
Why?
|
Myocardial Infarction | 6 | 2020 | 11458 | 0.550 |
Why?
|
Cardiovascular Agents | 4 | 2019 | 840 | 0.540 |
Why?
|
Prognosis | 37 | 2020 | 29620 | 0.540 |
Why?
|
Angiography | 3 | 2018 | 1599 | 0.500 |
Why?
|
Cachexia | 1 | 2016 | 202 | 0.480 |
Why?
|
Oxygen Consumption | 2 | 2017 | 1863 | 0.440 |
Why?
|
Echocardiography | 9 | 2020 | 4991 | 0.420 |
Why?
|
Natriuretic Peptides | 1 | 2014 | 155 | 0.410 |
Why?
|
Growth Differentiation Factor 15 | 1 | 2014 | 198 | 0.400 |
Why?
|
Patient Participation | 1 | 2021 | 1444 | 0.390 |
Why?
|
Outpatients | 4 | 2016 | 1597 | 0.380 |
Why?
|
Myocardium | 4 | 2017 | 4725 | 0.380 |
Why?
|
Coronary Artery Disease | 8 | 2020 | 6395 | 0.380 |
Why?
|
Predictive Value of Tests | 21 | 2020 | 15262 | 0.370 |
Why?
|
Coronary Circulation | 1 | 2017 | 1569 | 0.370 |
Why?
|
Echocardiography, Doppler, Pulsed | 1 | 2010 | 69 | 0.350 |
Why?
|
Protein Precursors | 4 | 2016 | 1133 | 0.340 |
Why?
|
Galectin 3 | 4 | 2015 | 240 | 0.330 |
Why?
|
Risk Assessment | 17 | 2019 | 23990 | 0.330 |
Why?
|
Coronary Stenosis | 4 | 2020 | 794 | 0.330 |
Why?
|
Heart Rate | 2 | 2019 | 4198 | 0.320 |
Why?
|
Chronic Disease | 15 | 2018 | 9320 | 0.320 |
Why?
|
Coronary Angiography | 7 | 2019 | 4472 | 0.310 |
Why?
|
Quality of Life | 4 | 2021 | 13361 | 0.290 |
Why?
|
Disease Management | 2 | 2018 | 2507 | 0.290 |
Why?
|
Guideline Adherence | 1 | 2017 | 2220 | 0.280 |
Why?
|
Aged | 56 | 2024 | 169235 | 0.270 |
Why?
|
Middle Aged | 53 | 2024 | 220826 | 0.270 |
Why?
|
Patient Readmission | 3 | 2018 | 3269 | 0.260 |
Why?
|
Prospective Studies | 25 | 2020 | 54415 | 0.260 |
Why?
|
Cardiac Pacing, Artificial | 1 | 2010 | 866 | 0.260 |
Why?
|
Proteomics | 4 | 2020 | 3845 | 0.260 |
Why?
|
Oxygen | 1 | 2017 | 4228 | 0.250 |
Why?
|
Follow-Up Studies | 21 | 2020 | 39117 | 0.240 |
Why?
|
Heart Failure, Diastolic | 2 | 2016 | 76 | 0.240 |
Why?
|
Emergency Service, Hospital | 5 | 2021 | 7874 | 0.240 |
Why?
|
Male | 62 | 2024 | 360736 | 0.230 |
Why?
|
Atrial Natriuretic Factor | 3 | 2015 | 350 | 0.230 |
Why?
|
Electrocardiography | 1 | 2017 | 6384 | 0.220 |
Why?
|
Humans | 84 | 2024 | 761423 | 0.220 |
Why?
|
Acute Disease | 8 | 2021 | 7238 | 0.220 |
Why?
|
Female | 64 | 2024 | 392581 | 0.220 |
Why?
|
Cause of Death | 5 | 2019 | 3684 | 0.200 |
Why?
|
Tetrazoles | 2 | 2019 | 909 | 0.190 |
Why?
|
Cardiovascular Diseases | 8 | 2019 | 15498 | 0.190 |
Why?
|
Electric Countershock | 1 | 2024 | 533 | 0.190 |
Why?
|
ROC Curve | 6 | 2020 | 3580 | 0.190 |
Why?
|
Disease Progression | 11 | 2018 | 13502 | 0.190 |
Why?
|
Medicare | 1 | 2019 | 6770 | 0.180 |
Why?
|
Habits | 1 | 2021 | 147 | 0.170 |
Why?
|
Neprilysin | 2 | 2020 | 478 | 0.170 |
Why?
|
Renal Insufficiency | 2 | 2016 | 809 | 0.170 |
Why?
|
Time Factors | 14 | 2020 | 39975 | 0.170 |
Why?
|
Hyperlipoproteinemias | 1 | 2019 | 20 | 0.160 |
Why?
|
Patient Selection | 2 | 2016 | 4244 | 0.160 |
Why?
|
Angiotensin Receptor Antagonists | 3 | 2020 | 1039 | 0.150 |
Why?
|
Echocardiography, Transesophageal | 1 | 2024 | 1088 | 0.150 |
Why?
|
Sodium Potassium Chloride Symporter Inhibitors | 2 | 2016 | 152 | 0.150 |
Why?
|
Treatment Outcome | 17 | 2019 | 64651 | 0.150 |
Why?
|
Amyloidosis | 1 | 2024 | 817 | 0.140 |
Why?
|
Aged, 80 and over | 15 | 2020 | 58956 | 0.140 |
Why?
|
Lipocalins | 2 | 2015 | 161 | 0.140 |
Why?
|
Systole | 2 | 2016 | 937 | 0.140 |
Why?
|
Tissue Survival | 1 | 2017 | 119 | 0.140 |
Why?
|
Nutrition Disorders | 1 | 2017 | 205 | 0.140 |
Why?
|
Apolipoproteins | 1 | 2019 | 326 | 0.140 |
Why?
|
Peripheral Arterial Disease | 2 | 2018 | 1272 | 0.140 |
Why?
|
Acute Kidney Injury | 3 | 2020 | 1924 | 0.140 |
Why?
|
Nutritional Sciences | 1 | 2017 | 144 | 0.130 |
Why?
|
Neurotensin | 1 | 2016 | 60 | 0.130 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 4 | 2016 | 1517 | 0.130 |
Why?
|
Risk Factors | 16 | 2019 | 74167 | 0.130 |
Why?
|
Adrenomedullin | 2 | 2015 | 85 | 0.130 |
Why?
|
Cystatin C | 2 | 2014 | 269 | 0.130 |
Why?
|
Receptors, Interleukin-1 | 2 | 2014 | 262 | 0.130 |
Why?
|
Catheterization | 2 | 2018 | 1432 | 0.130 |
Why?
|
Catheters | 1 | 2018 | 426 | 0.130 |
Why?
|
Glomerular Filtration Rate | 3 | 2018 | 2176 | 0.130 |
Why?
|
Necrosis | 2 | 2017 | 1608 | 0.130 |
Why?
|
Heart | 2 | 2020 | 4405 | 0.120 |
Why?
|
Blood Proteins | 2 | 2018 | 1180 | 0.120 |
Why?
|
Biphenyl Compounds | 2 | 2019 | 1007 | 0.120 |
Why?
|
Acetylglucosaminidase | 1 | 2014 | 66 | 0.120 |
Why?
|
Heart Ventricles | 3 | 2017 | 3816 | 0.120 |
Why?
|
Severity of Illness Index | 7 | 2019 | 15838 | 0.120 |
Why?
|
Catheterization, Peripheral | 1 | 2018 | 342 | 0.120 |
Why?
|
Troponin | 1 | 2018 | 501 | 0.120 |
Why?
|
Proportional Hazards Models | 6 | 2019 | 12456 | 0.110 |
Why?
|
Calcitonin | 1 | 2015 | 329 | 0.110 |
Why?
|
Immunoassay | 1 | 2017 | 746 | 0.110 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2017 | 10766 | 0.110 |
Why?
|
Vietnam | 1 | 2014 | 409 | 0.110 |
Why?
|
Limit of Detection | 1 | 2014 | 272 | 0.110 |
Why?
|
Patient Care | 1 | 2018 | 621 | 0.110 |
Why?
|
Behavior Therapy | 1 | 2018 | 880 | 0.100 |
Why?
|
Pneumonia, Bacterial | 1 | 2015 | 316 | 0.100 |
Why?
|
Survival Rate | 6 | 2017 | 12720 | 0.100 |
Why?
|
Risk Reduction Behavior | 1 | 2018 | 1112 | 0.100 |
Why?
|
Dizziness | 1 | 2014 | 259 | 0.100 |
Why?
|
Saphenous Vein | 1 | 2014 | 516 | 0.090 |
Why?
|
Fibrinogen | 1 | 2014 | 890 | 0.090 |
Why?
|
Ischemic Attack, Transient | 1 | 2016 | 882 | 0.090 |
Why?
|
Graft Occlusion, Vascular | 1 | 2014 | 537 | 0.090 |
Why?
|
Primary Prevention | 1 | 2018 | 1186 | 0.090 |
Why?
|
Age Factors | 4 | 2018 | 18400 | 0.090 |
Why?
|
Sex Factors | 4 | 2020 | 10548 | 0.090 |
Why?
|
Internationality | 1 | 2015 | 1001 | 0.090 |
Why?
|
Body Mass Index | 2 | 2019 | 12951 | 0.090 |
Why?
|
Feasibility Studies | 1 | 2021 | 5246 | 0.090 |
Why?
|
Terminology as Topic | 1 | 2017 | 1535 | 0.080 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2015 | 1135 | 0.080 |
Why?
|
Kaplan-Meier Estimate | 6 | 2016 | 6479 | 0.080 |
Why?
|
Myocardial Contraction | 1 | 2014 | 1517 | 0.080 |
Why?
|
Kidney Function Tests | 3 | 2016 | 678 | 0.080 |
Why?
|
United States | 8 | 2021 | 72339 | 0.080 |
Why?
|
Patient Compliance | 1 | 2019 | 2690 | 0.080 |
Why?
|
Randomized Controlled Trials as Topic | 6 | 2016 | 10203 | 0.080 |
Why?
|
Diagnosis, Differential | 3 | 2017 | 12970 | 0.080 |
Why?
|
Cardiology | 1 | 2019 | 1667 | 0.080 |
Why?
|
Health Care Costs | 1 | 2021 | 3243 | 0.070 |
Why?
|
Patient Admission | 1 | 2015 | 1367 | 0.070 |
Why?
|
Ambulatory Care | 2 | 2016 | 2775 | 0.070 |
Why?
|
Pilot Projects | 1 | 2021 | 8633 | 0.070 |
Why?
|
Reproducibility of Results | 4 | 2018 | 20093 | 0.070 |
Why?
|
Comorbidity | 2 | 2019 | 10498 | 0.070 |
Why?
|
Anxiety Disorders | 1 | 2018 | 2717 | 0.070 |
Why?
|
Incidence | 7 | 2019 | 21341 | 0.070 |
Why?
|
Hospitalization | 5 | 2021 | 10718 | 0.070 |
Why?
|
Diuretics | 3 | 2016 | 610 | 0.070 |
Why?
|
Attitude to Health | 1 | 2015 | 2025 | 0.070 |
Why?
|
Reference Values | 1 | 2014 | 4921 | 0.070 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2013 | 1651 | 0.070 |
Why?
|
Endothelium, Vascular | 1 | 2018 | 4430 | 0.070 |
Why?
|
Recovery of Function | 1 | 2016 | 2977 | 0.070 |
Why?
|
Statistics as Topic | 1 | 2012 | 2358 | 0.060 |
Why?
|
Proto-Oncogene Proteins | 2 | 2015 | 4510 | 0.060 |
Why?
|
Motor Activity | 1 | 2015 | 2711 | 0.060 |
Why?
|
Contrast Media | 1 | 2019 | 5311 | 0.060 |
Why?
|
Cohort Studies | 6 | 2019 | 41446 | 0.060 |
Why?
|
Depressive Disorder | 1 | 2018 | 3728 | 0.060 |
Why?
|
Coronary Artery Bypass | 1 | 2014 | 2189 | 0.060 |
Why?
|
Weight Loss | 1 | 2016 | 2683 | 0.060 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2018 | 2243 | 0.060 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2015 | 2898 | 0.060 |
Why?
|
Artificial Intelligence | 1 | 2019 | 2578 | 0.060 |
Why?
|
Membrane Glycoproteins | 1 | 2014 | 3702 | 0.060 |
Why?
|
Kidney Diseases | 1 | 2014 | 2092 | 0.060 |
Why?
|
Acute-Phase Proteins | 2 | 2015 | 250 | 0.060 |
Why?
|
Pulmonary Artery | 1 | 2012 | 1938 | 0.050 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2017 | 4014 | 0.050 |
Why?
|
Coronary Vessels | 1 | 2014 | 3096 | 0.050 |
Why?
|
Antihypertensive Agents | 1 | 2012 | 2023 | 0.050 |
Why?
|
Stents | 1 | 2014 | 3179 | 0.050 |
Why?
|
Sensitivity and Specificity | 4 | 2021 | 14664 | 0.050 |
Why?
|
Ultrasonography | 2 | 2012 | 5970 | 0.050 |
Why?
|
Exercise | 1 | 2018 | 5884 | 0.050 |
Why?
|
Practice Guidelines as Topic | 1 | 2019 | 7389 | 0.050 |
Why?
|
Tomography, Optical Coherence | 1 | 2014 | 2917 | 0.050 |
Why?
|
Research Design | 1 | 2016 | 6178 | 0.040 |
Why?
|
Clinical Trials as Topic | 1 | 2016 | 8000 | 0.040 |
Why?
|
Standard of Care | 2 | 2016 | 550 | 0.040 |
Why?
|
Adult | 9 | 2020 | 221148 | 0.040 |
Why?
|
Survival Analysis | 3 | 2019 | 10089 | 0.040 |
Why?
|
Obesity | 2 | 2019 | 12938 | 0.040 |
Why?
|
Massachusetts | 3 | 2018 | 8832 | 0.040 |
Why?
|
Kidney Failure, Chronic | 1 | 2012 | 2471 | 0.040 |
Why?
|
Cross-Sectional Studies | 3 | 2018 | 26112 | 0.040 |
Why?
|
Physicians | 1 | 2017 | 4591 | 0.040 |
Why?
|
Pharmacological Phenomena | 1 | 2019 | 11 | 0.040 |
Why?
|
Kidney | 1 | 2015 | 7049 | 0.040 |
Why?
|
Area Under Curve | 2 | 2015 | 1638 | 0.040 |
Why?
|
Analysis of Variance | 2 | 2019 | 6231 | 0.040 |
Why?
|
Decision Trees | 1 | 2021 | 504 | 0.040 |
Why?
|
Odds Ratio | 3 | 2015 | 9645 | 0.040 |
Why?
|
Principal Component Analysis | 1 | 2020 | 942 | 0.040 |
Why?
|
Depression | 1 | 2017 | 8122 | 0.040 |
Why?
|
Inflammation | 1 | 2017 | 10762 | 0.040 |
Why?
|
Multivariate Analysis | 3 | 2016 | 12058 | 0.030 |
Why?
|
Prevalence | 3 | 2018 | 15717 | 0.030 |
Why?
|
Economics, Hospital | 1 | 2018 | 210 | 0.030 |
Why?
|
Mortality | 2 | 2018 | 2900 | 0.030 |
Why?
|
Cost Savings | 1 | 2021 | 913 | 0.030 |
Why?
|
Retrospective Studies | 6 | 2020 | 80582 | 0.030 |
Why?
|
Lipoproteins, HDL | 1 | 2019 | 675 | 0.030 |
Why?
|
Adaptor Proteins, Vesicular Transport | 1 | 2016 | 306 | 0.030 |
Why?
|
Adiponectin | 1 | 2020 | 1113 | 0.030 |
Why?
|
Neointima | 1 | 2014 | 133 | 0.030 |
Why?
|
Endpoint Determination | 1 | 2016 | 590 | 0.030 |
Why?
|
Confidence Intervals | 1 | 2019 | 2927 | 0.030 |
Why?
|
Angiotensin II Type 1 Receptor Blockers | 1 | 2016 | 431 | 0.030 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 2017 | 1125 | 0.030 |
Why?
|
Aging | 1 | 2012 | 8705 | 0.030 |
Why?
|
Solubility | 1 | 2015 | 1091 | 0.030 |
Why?
|
Creatinine | 1 | 2019 | 1899 | 0.030 |
Why?
|
Blood Chemical Analysis | 1 | 2015 | 437 | 0.030 |
Why?
|
Animals | 2 | 2017 | 168441 | 0.030 |
Why?
|
Drug Combinations | 1 | 2019 | 2048 | 0.030 |
Why?
|
Drug Monitoring | 1 | 2019 | 962 | 0.030 |
Why?
|
International Classification of Diseases | 1 | 2018 | 909 | 0.030 |
Why?
|
Calcitonin Gene-Related Peptide | 1 | 2015 | 323 | 0.030 |
Why?
|
Cardiomyopathies | 1 | 2024 | 1964 | 0.030 |
Why?
|
Vasodilator Agents | 1 | 2016 | 973 | 0.020 |
Why?
|
Mass Spectrometry | 1 | 2019 | 2192 | 0.020 |
Why?
|
Digoxin | 1 | 2012 | 246 | 0.020 |
Why?
|
Drug Substitution | 1 | 2014 | 290 | 0.020 |
Why?
|
Receptors, Virus | 1 | 2014 | 640 | 0.020 |
Why?
|
Hyperplasia | 1 | 2014 | 1152 | 0.020 |
Why?
|
Interleukin-17 | 1 | 2017 | 911 | 0.020 |
Why?
|
Patient Care Planning | 1 | 2016 | 908 | 0.020 |
Why?
|
Echocardiography, Doppler | 1 | 2014 | 898 | 0.020 |
Why?
|
Galectins | 1 | 2013 | 295 | 0.020 |
Why?
|
Electric Impedance | 1 | 2014 | 756 | 0.020 |
Why?
|
Heart-Assist Devices | 1 | 2020 | 1287 | 0.020 |
Why?
|
Peroxidase | 1 | 2012 | 609 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2015 | 3418 | 0.020 |
Why?
|
C-Reactive Protein | 1 | 2020 | 3823 | 0.020 |
Why?
|
Quality Indicators, Health Care | 1 | 2018 | 1792 | 0.020 |
Why?
|
Activities of Daily Living | 1 | 2016 | 2421 | 0.020 |
Why?
|
Young Adult | 1 | 2014 | 59207 | 0.020 |
Why?
|
Up-Regulation | 1 | 2016 | 4124 | 0.020 |
Why?
|
Cholesterol, LDL | 1 | 2016 | 2382 | 0.020 |
Why?
|
Linear Models | 1 | 2016 | 5869 | 0.020 |
Why?
|
Dietary Supplements | 1 | 2018 | 3414 | 0.020 |
Why?
|
Atrial Fibrillation | 1 | 2024 | 5127 | 0.020 |
Why?
|
Boston | 1 | 2018 | 9330 | 0.020 |
Why?
|
Referral and Consultation | 1 | 2018 | 3600 | 0.020 |
Why?
|
Models, Biological | 1 | 2020 | 9469 | 0.010 |
Why?
|
Quality of Health Care | 1 | 2018 | 4330 | 0.010 |
Why?
|
Genetic Testing | 1 | 2016 | 3538 | 0.010 |
Why?
|
Gene Expression | 1 | 2015 | 7584 | 0.010 |
Why?
|
Hemodynamics | 1 | 2012 | 4168 | 0.010 |
Why?
|
Registries | 1 | 2018 | 8223 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2018 | 14599 | 0.010 |
Why?
|
Electronic Health Records | 1 | 2019 | 4811 | 0.010 |
Why?
|
Health Status | 1 | 2012 | 4075 | 0.010 |
Why?
|
Intensive Care Units | 1 | 2012 | 3744 | 0.010 |
Why?
|
Phenotype | 1 | 2015 | 16606 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2016 | 15941 | 0.010 |
Why?
|